TRIGYN — Trigyn Technologies Balance Sheet
0.000.00%
- IN₹2.53bn
- -IN₹1.57bn
- IN₹8.98bn
- 91
- 94
- 32
- 86
Annual balance sheet for Trigyn Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,964 | 2,151 | 1,381 | 3,829 | 4,234 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,455 | 2,915 | 3,785 | 2,584 | 2,566 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,618 | 5,178 | 5,518 | 6,823 | 7,203 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 60.4 | 85.7 | 116 | 75.1 | 49.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 6,829 | 7,549 | 8,561 | 8,737 | 9,034 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,149 | 1,402 | 1,640 | 1,603 | 1,496 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,248 | 1,473 | 1,751 | 1,725 | 1,624 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 5,581 | 6,076 | 6,810 | 7,012 | 7,411 |
Total Liabilities & Shareholders' Equity | 6,829 | 7,549 | 8,561 | 8,737 | 9,034 |
Total Common Shares Outstanding |